Cheng et al. report that analysing structural brain changes across four large datasets, using advanced segmentation, reveals robust associations of Alzheimer’s disease CSF biomarkers (amyloid, tau) with brain volumes, morphometric connectomes and sex differences. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.